SCHEMBL18495442

SCHEMBL18495442

CC(C)(O)C(O)CC[C@@H](I)C1C(O)C[C@@]2(C)C3CCC4C(C)(C)C(=O)CC[C@@]45C[C@@]35CCC12C

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.42
▸ HSD11B2 P80365 1/20 0.40
▸ ACHE P22303 2/20 0.39
▸ NR1H4 Q96RI1 7/20 0.39
▸ CES2 O00748 4/20 0.39
▸ FNTA P49354 1/20 0.36
▸ FNTB P49356 1/20 0.36
▸ TOP2A P11388 5/20 0.34
▸ TOP2B Q02880 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20279382 0.91 HSD11B1 (0.47) HSD11B1HSD11B2ACHENR1H4CES2
SCHEMBL20284781 0.91 HSD11B1 (0.47) HSD11B1HSD11B2ACHENR1H4CES2
SCHEMBL29843558 0.81 HSD11B1 (0.43) HSD11B1HSD11B2ACHENR1H4CES2
SCHEMBL5824299 0.78 HSD11B1 (0.61) HSD11B1HSD11B2ACHENR1H4CES2
SCHEMBL4232501 0.73 HSD11B1 (0.62) HSD11B1HSD11B2ACHEFNTAFNTB
SCHEMBL4232495 0.73 HSD11B1 (0.62) HSD11B1HSD11B2ACHEFNTAFNTB
Argentatine A SCHEMBL18495437 0.70 TYR (0.48) HSD11B1NR1H4CES2
Argentatine A SCHEMBL20888305 0.70 TYR (0.48) HSD11B1NR1H4CES2
Argentatine A SCHEMBL18495439 0.70 TYR (0.48) HSD11B1NR1H4CES2
Argentatine A SCHEMBL20279380 0.70 TYR (0.48) HSD11B1NR1H4CES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3328874-B1 METHOD FOR THE SEPARATION OF THE ISOPRENIC CONSTITUENTS OF GUAYULE VERSALIS SPA (IT) 2019-11-06 — — EP disclosed
WO-2017021852-A1 METHOD FOR THE SEPARATION OF THE ISOPRENIC CONSTITUENTS OF GUAYULE VERSALIS S.P.A. (IT) 2017-02-09 — — WO disclosed
Send feedback